Literature DB >> 15256285

A novel role for cholecystokinin: regulation of mesenteric vascular resistance.

Cristina Sánchez-Fernández1, M Carmen González, Philip M Beart, Linda D Mercer, Mariano Ruiz-Gayo, María S Fernández-Alfonso.   

Abstract

The aim of this work was to characterize the vasoactive effect of cholecystokinin on mesenteric vasculature. The mesenteric vascular bed of 3-month-old Sprague-Dawley rats was isolated and perfused at constant flow and changes in perfusion pressure monitored. CCK peptides lacked any direct contractile or relaxing effect on the mesenteric smooth muscle. Transmural nerve stimulation (TNS, 200 mA, 0.2 ms, 8 and 16 Hz) elicited an increase in perfusion pressure reflecting contraction of the bed and CCK inhibited neurogenic contractions elicited by 8 and 16 Hz TNS. The inhibition of neurogenic contractions was blocked by the CCK2 receptor (CCK2R) antagonist, L-365,260 (10 and 100 nM), but not by the CCK1R antagonist, SR-27897. The inhibition of neurogenic contractions was reversed by the non-specific NOS inhibitor, L-NAME as well as by the specific nNOS inhibitor, S-methyl-L-thiocitrulline. In whole-mount segments of mesenteric arteries, CCK2R was detected in the adventitia, in nerve terminals, where it co-localized with synaptophysin and nNOS. CCK-8 immunoreactive fibers were also detected. These results suggest that CCK mediates vasodilatation of the mesenteric vascular bed through the release of NO via its presynaptic CCK2R. Our findings provide, for the first time, a neural mechanism by which CCK may increase mesenteric blood flow. Copyright 2004 Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15256285     DOI: 10.1016/j.regpep.2004.04.018

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  7 in total

1.  The gastrointestinal peptide obestatin induces vascular relaxation via specific activation of endothelium-dependent NO signalling.

Authors:  Andrew J Agnew; Emma Robinson; Carmel M McVicar; Adam P Harvey; Imran H A Ali; Jennifer E Lindsay; Denise M McDonald; Brian D Green; David J Grieve
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

2.  Mesenteric vascular dysregulation and intestinal inflammation accompanies experimental spinal cord injury.

Authors:  Emily M Besecker; Gina M Deiter; Nicole Pironi; Timothy K Cooper; Gregory M Holmes
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-11-09       Impact factor: 3.619

3.  Effect of Cholecystokinin-8 (CCK-8) on Blood Pressure and Blood Content of Calcitonin-Gene-Related Peptide (CGRP) in Rats with Hypertension Caused by Fructose or Inhibition of Nitric Oxide Synthesis.

Authors:  Z S Tolochko; V K Spiridonov
Journal:  Bull Exp Biol Med       Date:  2021-10-07       Impact factor: 0.804

4.  A cholecystokinin-1 receptor agonist (CCK-8) mediates increased permeability of brain barriers to leptin.

Authors:  V Cano; B Merino; L Ezquerra; B Somoza; M Ruiz-Gayo
Journal:  Br J Pharmacol       Date:  2008-04-21       Impact factor: 8.739

5.  The role of NMDA and non-NMDA receptors in the NTS in mediating three distinct sympathoinhibitory reflexes.

Authors:  Daniela M Sartor; Anthony J M Verberne
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-11-16       Impact factor: 3.000

6.  Is there adaptation of the exocrine pancreas in wild animal? The case of the Roe deer.

Authors:  Paul Guilloteau; Francesca Vitari; Valérie Metzinger-Le Meuth; Laurence Le Normand; Véronique Romé; Gérard Savary; Luc Delaby; Cinzia Domeneghini; Jean Morisset
Journal:  BMC Vet Res       Date:  2012-05-28       Impact factor: 2.741

7.  Conceptualization of a Parasympathetic Endocrine System.

Authors:  Jonathan Gorky; James Schwaber
Journal:  Front Neurosci       Date:  2019-09-23       Impact factor: 4.677

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.